Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aarey Drugs & Pharmaceuticals Limited has submitted its financial results for the quarter and financial year ended March 31, 2025 to the stock exchange. The announcement itself is a standard regulatory filing notification confirming timely submission. No specific financial figures, revenue, profit, or loss numbers are disclosed in the headline text provided. Investors would need to refer to the actual results document for detailed performance metrics.
This is a routine compliance filing with no direct impact on shareholders or stock price on its own. Investors should review the detailed financial results to assess the company's annual performance before making any decisions.